The role of cellular flice inhibitory protein (c-FLIP) in the pathogenesis and treatment of cancer
- 27 January 2006
- journal article
- review article
- Published by Taylor & Francis in Emerging Therapeutic Targets
- Vol. 10 (1) , 27-35
- https://doi.org/10.1517/14728222.10.1.27
Abstract
(2006). The role of cellular flice inhibitory protein (c-FLIP) in the pathogenesis and treatment of cancer. Expert Opinion on Therapeutic Targets: Vol. 10, No. 1, pp. 27-35.Keywords
This publication has 91 references indexed in Scilit:
- Potent and persistent in vivo anti-HBV activity of chemically modified siRNAsNature Biotechnology, 2005
- Death to the bad guys: Targeting cancer via Apo2L/TRAILApoptosis, 2005
- Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplificationOncogene, 2002
- Targeting death and decoy receptors of the tumour-necrosis factor superfamilyNature Reviews Cancer, 2002
- Death and anti-death: tumour resistance to apoptosisNature Reviews Cancer, 2002
- Selective Expression of FLIP in Malignant Melanocytic Skin LesionsJournal of Investigative Dermatology, 2001
- Safety and antitumor activity of recombinant soluble Apo2 ligandJournal of Clinical Investigation, 1999
- CD40 and its ligand: Central players in B lymphocyte survival, growth, and differentiationBlood Reviews, 1995
- Fas-mediated cytotoxicity by freshly isolated natural killer cells.The Journal of Experimental Medicine, 1995
- The effects of Hodgkin's disease and combination chemotherapy on gonadal function in the adult maleCancer, 1982